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ABSTRACT 
The aims of this study were 1) to describe the effects of a 54km and 111km ultra-
endurance mountain race on the biomarkers of muscle damage and inflammation, 2) to 
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compare the effects between the two races regarding the biomarkers of muscle damage and 
inflammation.  
Sixteen ultra-endurance amateur runners volunteered to participate in this study. Ten 
runners completed a 54km race (Group 1; age: 27.0±5.7; height: 179.5±5.8cm; and body 
mass: 77.3±10.7Kg) and six completed a 111km race (Group 2; age: 30.5±8.0; height: 
179.4±5.5cm; and body mass: 76.2±9.4Kg). Blood samples were taken at five different 
points during the investigation, 24hrs before the race, immediately post-race, and again at 
24, 48, and 72hrs after the race.  
There were increases in leukocyte (Group 1: p = < 0.001, ES = 2.8; Group 2: p = 0.001, ES 
= 3.5) and platelet concentrations (Group 1: p = < 0.001, ES = 2.3; Group 2: p = 0.02, ES = 
1.7) post-races. Significant inter-race differences were also observed in leukocyte at 72hrs 
(Group 1: 5.5 ± 0.9, Group 2: 4.2 ± 0.9, p = 0.012, ES = 1.5). Erythrocytes, hematocrit and 
hemoglobin concentration decreased after 54km and 111km races at 24, 48 and 72hrs (p = 
<0.001, ES = 2.0 – 3.18). Serum uric acid concentration increased after the 54km race (pre 
= 4.9 ± 1.2 – post = 7.3 ± 1.0 8 mg/dl; p = < 0.001, ES = 2.4), and also the 111km race (pre 
= 5.3 ± 0.9 – post = 6.7 ± 0.8 mg/dl; p < 0.008, ES = 2.2). GPT, GOT and LDH had 
changed by the end of the races (p<0.05) and differences between the groups were 
observed in GOT post-race (p = 0.008, ES = 1.7) 24hrs (p = 0.004, ES = 1.8), 48hrs (p = 
0.007, ES = 1.6), and 72hrs (p = 0.02, ES = 1.4) and also in LDH at 24, 48, 72hrs. Serum 
creatinine decreased post-race in Group 1 (pre = 1.1 ± 0.1 – post = 1.4 ± 0.2 mg/dl; p = 
0.001, ES = 1.5) and Group 2 (pre = 1.2 ± 0.1, post = 1.5 ± 0.2; p = 0.002, ES = 3.3) along 
with CK and myoglobin. In addition, values did not return to baseline levels after 72hrs in 
Group 2 for C-reactive protein, myoglobin, and CK. Differences between the races were 
also observed post-race in Troponin I (Group 1 = 0.06 ± 0.05, 111km = 0.02 ± 0.01 µg/l, p 
= 0.047, ES = 1.1) and C-reactive protein post-race (Group 2 = 2.5 ± 1.6, 111km = 18.2 ± 
6.4 mg/l, p = < 0.001, ES = 4.4) at 24 and 48hrs. 
The athletes had increased concentrations of markers associated with damage, 
inflammation, muscle injury and cardiac damage after the races. Furthermore, athletes who 
completed the greater distance (111km) had higher concentrations of the markers 
associated with muscle damage and muscle inflammation which remained changed for a 
period of 72 hours. However, the participants of the ‘shorter race’ showed higher values 
associated with cardiac damage. Consequently, athletes who take part in these kinds of 
races should wait at least 72 hours before training with high load. 
 
Key words: Hematocrit and hemoglobin, CK, LDH, C-Reactive Protein, Transaminases. 
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1. Introduction 
Regular physical activity is beneficial for cardiovascular health, enhances parts of the 
innate immune system, and reduces the risk of infection [1, 2]. Aerobic training has been 
promoted as healthy physical activity that provides positive effects on the cardiovascular 
system. Therefore, in recent times, endurance and ultra-endurance races have begun to 
become very popular and the participation of athletes has increased [3]. These ultra-
endurance races or ultra-marathon races can be classified by distance, elevation and the 
environment, there are different types of ultra-endurance races and ultra-marathon 
mountain races. The athletes can perform a mountain race over great elevation, alternating 
walking and running according to distance and modality of the event [4].  
Several studies have investigated the acute changes in muscle injury related biomarkers 
along with inflammation and muscle damage after ultra-endurance races [5, 6]. The 
exercise-induced muscle damage is accompanied by the presence of a systemic 
inflammatory response, which protects the athlete’s body from further damage [7, 8].  
Several studies have used blood marks to evaluate the inflammation damage and cardiac / 
muscle injury after participation in ultra-endurance races. The ultra-endurance races can 
induce hemolysis (loss of erythrocytes, decreases in hematocrit) [6] or a process of 
inflammation induced by exercise stress [9]. Furthermore, exercise-induced inflammation 
appears to modulate homeostasis of the bone marrow, leading to increased leukocyte 
turnover and decreased erythroid compartment[10]. The creatine kinase (CK) 
concentration, as well as inflammatory and infection markers such as C-Reactive Protein 
(CRP) [11], liver injury lactate dehydrogenase (LDH) or cardiac pathology markers (i.e. 
cardiac troponin I) may be high for several days after strenuous ultra-endurance exercise 
[8]. Therefore, well established muscle damage after ultra-endurance exercise, promotes 
higher values of plasma enzymes such as myoglobin or CK concentrations and liver 
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damage indicators such LDH.  
In addition, these biomarkers can be elevated for a few days and can impair athlete’s health 
due to the appearance of rhabdomyolysis [12]. Moreover, there are few studies that have 
analysed the modulation of biochemical markers during the hours following the end of the 
race [13]. Neubauer, Konig [7] analysed the response of the inflammatory markers after an 
Ironman triathlon race, and concluded that muscle inflammation markers returned to 
baseline levels after 5-19 days. Marklund, Mattsson [14] concluded that although ultra-
endurance races were performed with low-intensity, these races were very prolonged and 
induced an extensive infiltration of inflammatory cells into the skeletal muscles of well-
trained athletes even 28hrs after exercise cessation. Previously published studies have been 
limited to analysing just the acute effect of different ultra-endurance races on muscle 
damage biomarkers and the inflammatory response. However, few studies have analysed 
the evolution and recovery of these parameters over the subsequent days.  
Running over longer distances could cause minor muscle damage [6], but the distances 
which also include higher elevations might lead to increased levels of induced muscle 
damage[6, 15]. In some instances, ultra-endurance races are considered extreme exercise 
events because induce cardiac dysfunctions [16] increase inflammatory markers, muscle 
and myocardial damage [11, 13], mainly, with over very long-distance races [17]. For 
example, Waskiewicz, Klapcinska [17] found that CK increased 3.1, 17.1 and 70 times 
after the first 42km, 12 and 24hrs respectively, during a 168km ultra-endurance race. 
Therefore, the distance covered by the athletes seems to influence and affect the muscle 
damage and inflammation biomarkers, as well as the recovery process. However, there are 
no studies that have compared the acute biochemical effects of a “short” endurance 
mountain race (~50km) vs. a long ultra-endurance mountain race (~100km). Thus, the 
study provides an important opportunity to advance the understanding of the acute effects 
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according to the two different distances of ultra-endurance races on muscle damage and 
inflammation biomarkers as well as recovery time. Furthermore, the data could help to 
understand the importance of recovery before returning to training to optimize the training 
load. Therefore, the aims of this study were: 1) to determine the alterations in muscle 
damage and inflammation biomarkers of amateur runners immediately after a race, and 
again 24hrs, 48hrs and 72hrs after finishing either a 54km or 111km ultra-endurance 
mountain race; 2) to compare the differences in the acute response in serum concentration 
of muscle damage and inflammatory response between the two distances of the ultra-
endurance mountain race events (54 vs 111km)  
 
2. Material and Methods 
2.1 Design 
A comparative description (cross-sectional study) was conducted to analyse the effects of 
two different ultra-marathons (54km and 111km) on muscle damage, inflammation and 
muscle injury markers.  
2.2 Participants  
Sixteen ultra-endurance male runners volunteered to participate in this study (age: 30.5 ± 
8.0 years; height: 179.4 ± 5.5 cm; body mass: 76.2 ± 9.4 Kg). Participants enrolled in a 
short-distance (Group 1) or long-distance (Group 2) race depending on their previous 
experience. Finally, ten runners enrolled in the 54km race (short-distance; Age: 27.0 ± 5.7 
years; Height: 179.5 ± 5.8 cm; Body mass: 77.3 ± 10.7 Kg; BMI: 23.92 ± 2.4 kg/m2; Body 
fat: 11.9 ± 3.2 %; Fat free mass: 64.5 ± 7.6 kg) and six completed the 111km race (long-
distance; age: 30.5 ± 8.0 years; height: 179.4 ± 5.5 cm; body mass: 76.2 ± 9.4 Kg; BMI: 
22.98 ± 2.0 kg/m2; Body fat: 11.4 ± 2.0 %; Fat free mass: 60.9 ± 5.9 kg). All participants 
were amateur athletes who had participated in ultra-endurance events for at least four 
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years. The participants were recruited by phone according to the following inclusion 
criteria: aged 18-40 years old; at least four years of endurance training experience, and 
who exercised five times per week; participation in the previous edition of the Castle of 
Cartagena race with a race time of <7.5hrs; and no musculoskeletal disorders in the 
previous six months before the study. Prior to the race, the experimental procedures and 
risk and discomforts associated with the study were explained to all participants and they 
provided a signed informed consent. The study was approved by the University’s 
Institutional Review Board and was in accordance with the Declaration of Helsinki. Lastly, 
the runners completed a questionnaire on training status according to Smith et al. [18] 
2.3 Methodology 
The data collection was performed on five different days, hematological tests were 
conducted on the athletes in a laboratory setting, blood samples were taken 24hrs before 
the race (pre-race), immediately post-race, and at 24, 48 and 72 hrs after the race. The 
blood sample (6.5 ml) was withdrawn from an antecubital vein using a sterile technique to 
analyse hematological variables. Lastly, 10 participants took part in a 54km race, with 
2726m of ascent and 2665m of descent, and 6 participants completed a 111km race that 
included 4474m of ascent and 4420m of descent. Furthermore, on the first visit, height 
(cm) and body mass (kg) were assessed with a digital stadiometer Seca 700 (Seca® Ltd, 
Germany). Additionally, a body composition analysis using the direct Segmental Multi-
Frequency Bioelectrical Impedance Analysis Method (model type: BC-601, Tanita, Japan) 
was determined following the manufacturer’s guidelines. 
The extraction of blood was performed while the subject was seated. Three millilitres of 
the sample were placed into a tube containing EDTA to determine hemoglobin 
concentration and Hematocrit, erythrocytes, white blood cell and platelet counts using a 
hematology analyser (System XS-1000i. Kobe. Kansai. Japan). The remaining 3.5ml 
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sample was allowed to clot and was centrifuged for 10mins at 5000 x g to separate out the 
serum. Blood markers of muscle damage and biochemical parameters (leukocytes, 
platelets, erythrocytes, hemoglobin, hematocrit, Mean Corpuscular Volume; MCV, Mean 
Corpuscular Hemoglobin; MCH, Uric Acid, LDH, Creatinine, CK and myoglobin) and 
hepatic enzymes (GOT, GPT) were then analysed by automated chemical analysis (IL 
ILAB 600 Chemistry Analyzer of Instrumentation Laboratory. Holliston. MA. USA) using 
the serum. 
2.4 Statistical Analysis 
Statistical analysis was performed with the Statistical Package for the Social Sciences 
(SPSS, version 21, SPSS Inc, Chicago, IL, USA). Standard descriptive statistics were 
performed (mean and standard deviations). For the inferential analysis, a Shapiro-Wilk 
Test was performed to establish the normality of sampling distribution. A General Lineal 
Model (repeated measures ANOVA) was used to investigate differences in hematological 
variables between, pre-race, at the finish, 24hrs, 48hrs and 72hrs post-race and inter-race. 
All data is reported as mean (±SD) with the statistical significance set at p≤0.05. The effect 
size (ES) was calculated using Cohen’s guidelines [19]: 𝐸𝑆 =
𝑀𝑝𝑟𝑒 −𝑀𝑝𝑜𝑠𝑡
𝑆𝐷𝑝𝑟𝑒
(1 −
3
4𝑛 − 5
) for 
related samples and ES = 
(𝑀𝑔1−𝑀𝑔2 )
𝑆𝐷𝑝𝑜𝑜𝑙
 for independent samples, where M is the mean (Mpre= 
mean before the exercise program; Mpost= mean after the exercise program; Mg1= mean of 
the first group after the exercise program and Mg2= mean of second group after the 
exercise program; SDpool= √
(𝑛1−1)𝑆𝐷1
2 +(𝑛2−1)𝑆𝐷2
2
𝑛1+𝑛2−2
,  is the standard deviation, and n is the 
sample size. The effect size (ES, 95% confidence limit) in the selected variables was 
calculated using the SD. Threshold values for Cohen ES statistics were >0.2 (small), >0.6 
(moderate), >1.2 (large), and >2.0 (very large)[20]  
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3. Results  
No significant differences were observed between the 111km race runners and the 54km 
race runners in anthropometrics data (Height: p = 0.576, ES = 0.34 [- -0.83 - 1.5]; Body 
mass: p = 0.419, ES = 0.49 [-0.68 - 1.7]; Body fat: p = 0.770, ES = 0.189 [-1.0 - 1.3]; Fat 
free mass: p = 0.410, ES = 0.506 [-0.7 - 1.7]. All runners completed the races, with the 
54km race runners averaging 6hrs 41min and 43s. On the other hand, the 111km race 
runners completed the race in an average of 18hrs 16min and 38s (Figure 1).  
---Insert figure 1--- 
Complete Blood Count basic measures  
Significant increases in leukocyte concentration post-race were observed (Table 1). 
Exclusively, there were significant inter-race differences (favours 111km, Figure 2) at 
72hrs in leukocyte concentration (p = 0.012, ES = 1.5 [2.6 – 0.3]) (Figure 2). Immediately 
after the races, there was an increase in platelet concentrates (Group 1: p = <0.001, ES = 
2.3 [1.1 – 3.5] Group 2: p = 0.02, ES = 1.7 [0.2 – 3.1]). Nevertheless, in Group 2, the 
platelet concentrates had decreased to baseline levels after 24hrs (p = 0.043; ES = 1.1 [0.03 
– 2.1]) and 48hrs (p = 0.003, ES = 2.2 [0.6 – 3.6]). Erythrocytes, hemoglobin and 
hematocrit concentration decreased in Group 1 and Group 2 at 24, 48 and 72hrs (Table 1).  
 
---Insert table 1 and Figure 2--- 
 
Muscle damage, inflammation and muscle injury markers 
Serum uric acid concentration was higher after race in Group 1 (p<0.001, ES = 2.4 [1.1 – 
3.6]) and Group 2 (p = 0.008, ES = 2.2 [0.5 – 3.9]). Moreover, GPT and GOT had 
increased post-race (Table 2). In Group 1 and Group 2, increases of GPT remained 
elevated after 72hrs. Besides, GOT levels increased during race in Group 1, but decreased 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
to basal levels in the following 24 and 72hrs in group 2, although in Group 2, the increase 
in GOT levels remained unchanged even after 72hrs. There were differences in GOT 
values between races (favours Group 2, Figure 3), post-race (p = 0.008, ES = 1.7 [0.4 – 
3.0]) as well as at 24hrs (p = 0.004, ES = 1.7 [0.5 – 2.9]), 48hrs (p = 0.007, ES = 1.6 [0.4 – 
2.8]) and 72hrs (p = 0.003, ES = 1.8 [0.5 – 3.0]). Moreover, an increase in LDH 
concentration were observed post-races (Group 1 and Group 2), and by 72hrs an increase 
as compared to baseline was also shown in the Group 2. Moreover, higher values of LDH 
concentration were observed in Group 2 than in Group 1 at 24hrs (p = 0.02, ES = 1.3 [0.2 – 
2.9]), 48hrs (p = 0.006, ES = 1.7 [0.5 – 2.8]) and 72hrs (p = 0.006, ES = 1.7 [0.5 – 2.9]) 
(Figure 3). 
 
---Insert Table 2 and Figure 3--- 
 
Serum creatinine increased post-race in Group 1 (p = 0.001, = 1.4 [0.5 – 2.3]) and Group 2 
(p = 0.002, ES = 3.3 [1.0 – 5.7]) (Table 3) although in Group 2, it was reduced from 48 to 
72hrs. In addition, serum markers of muscle damage (CK, myoglobin, troponin I, C-
Reactive Protein) increased at the end of the race after and 24, 48 and 72hrs (Table 3). 
Furthermore, greater increases were found in muscle damage in participants who 
completed the 111km (Group 2) in CK post-race (p = 0.003, ES = 2.0 [0.7 – 3.3]) and at 
24hrs (p = 0.053, = 1.1 [0.0 – 2.2]), in C-Reactive Protein after race (p < 0.001, ES = 4.2 
[2.2 – 6.0]), at 24hrs (p = 0.033, ES = 1.2 [0.1 – 2.3]) and 48 hrs (p = 0.022, ES = 1.3 [0.2 
– 2.4]) after race. However, higher values in participants who completed the 54km (Group 
1) in Troponin I after race (p = 0.047, ES = 1.1 [0.0 – 2.2]) (Figure 4). 
 
---Insert table 3 and Figure 4--- 
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4. Discussion 
The aims of this study were: a) To investigate hematological variations-related changes in 
participants in a 54km or 111km ultra-endurance mountain running event b) to determine 
what type of run/distance produced greater changes on hematological variations in 
participants. The main findings of this study were: a) running an ultra-endurance mountain 
race resulted in highly significant increases in muscle damage and inflammation markers; 
b), The baseline values of muscle damage remained significantly elevated after 72 hours 
post-race, especially in the 111km runners, with statistically significant differences being 
observed between groups. 
 
Complete Blood Count basic measures  
After analysing the red blood cell series, erythrocytes, hemoglobin and hematocrit, we 
observed that hemoglobin and hematocrit values trended toward below normal in the pre-
competition period in both shorter and longer-distance runners. This could be because they 
are well-trained athletes in endurance sports [5]. The trend in both tests right after 
competing was of maintenance compared to baseline values, by physiological 
hemoconcentration caused by decreased plasma volume [21] and dehydration [22].  
The ultra-marathon mountain races (54km and 111km) led to hemolysis in the participants 
with a loss of erythrocytes, hemoglobin and hematocrit at 24hrs, 48hrs and 72hrs after 
finishing the race. These results agree with previous works, Yusof et al. [23] observed a 
loss erythrocyte (6 - 9%) in male runner after 216km.  Robach et al. [24] found that after a 
166km ultra-marathon mountain race, hemolysis occurred but it was mainly a response 
after competition due to hemodilution that was maintained for several days depending on 
the duration of the race [25]. This blood cell lysis could be due to factors such as 
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mechanical haemolytic anemia involving microtraumatism from running impact [11, 26]. 
In addition, one of the hemolytic functions is to maintain higher temperatures. However, 
the longer this high temperature is maintained, the more muscle damage is generated. [22, 
27].  
In addition, after race we observed an increase of leukocytes (Group 1 = 176.3%, ES: 2.8; 
Group 2 = 159.2%, ES: 3.5) and platelets (Group 1 = 24.1%, ES: 2.3; Group 2 = 23.9, ES: 
1.7) in both races. Furthermore, a decrease of platelets from baseline was found (Group 1 = 
24.1%, ES: 2.3; Group 2 = 23.9, ES: 1.7) after race and at 24hrs (Group 1 = 9.5%, ES: 0.5; 
Group 2 = 6.1%, ES: 1.1). These results agree with a previous work carried out by 
Zakovska, Knechtle [9] who concluded that after 100km ultra-marathon under cold 
conditions that the leukocytes increased post-race by 185.3%. Shin and Lee [28] conclude 
that prolonged endurance ultra-endurance running was associated with perturbation in 
leukocyte subsets. A possible explanation for this might be that the increased leucocytes 
and platelets seem to be due to the stress on the immune system and acute inflammation of 
the organism caused by tissue injury [9, 28]. 
 
Muscle damage, inflammation and muscle injury markers 
The results of this study showed an increase of uric acid concentration after races in 54km 
(49%, ES: 2.4) and in 111km (26.4%, ES: 2.2). These results were in agreement with  
Waring, Convery [29], which showed that an increase of the concentration of uric acid 
increased serum antioxidant capacity and reduced exercise-induced oxidative stress in a 
young healthy population. On the other hand, there were increases in GPT (Group 1: 
24.8%, ES: 1.1; Group 2: 120%, ES: 3.2) and GOT (Group 1: 108%, ES: 2.0; Group 2: 
672%, ES: 2.1) activity and these values did not return to baseline level after 72hrs. 
Previous studies have pointed out that an increase in CK, myoglobin and GOT after an 
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ultra-endurance race indicates exertional rhabdomyolysis and skeletal muscle leakage, 
while GPT is a hepatic injury marker [12]. Therefore, the high production of GOT could 
lead hepatic injuries, mainly in long distances races.   
The level of CK increased after both races (Group 1: 150%, ES: 1.5; Group 2: 5059%, ES: 
2.0) with differences between races (ES: 2.0). These results are consistent with data 
obtained from a 200km ultra-marathon, where mean CK values increased 19-fold at 
100km, and 90-fold at the end of the race as compared to pre-race values [30]. This 
difference has been previously described by Waskiewicz, Klapcinska [17], who found that 
serum activity of CK increased 3.1, 17.1 and 70 times after the first 42km, 12hrs and at the 
end of a 24hrs (168 km) ultra-endurance race, respectively. In our study, maximum levels 
of CK were reached immediately after the races, and decreased over the next 72hrs, 
without reaching basal values in the 111km race. This result corroborates the ideas of 
previous studies where 5 or more days are needed for CK to return to basal values after an 
ultra-endurance race (100-166km) [31, 32]. The differences in damage and inflammation 
biomarkers between groups may be explained by the greater elevation gains and losses in 
the 111km race [3], the greater number of eccentric contractions, and the duration of the 
race. Thus, the increase of CK activity after the race depends on the type and duration of 
the exercise [33]. Thus, this result may be explained by the fact that in mountain ultra-
endurance races, the eccentric component and the continuous foot strikes gain importance 
in increasing the values of CK [34].  
In the same way, increases in myoglobin (Group 1: 6671%, ES: 1.7; Group 2: 8470%, ES: 
2.2) and LDH (Group 1: 80%, ES: 4.4; Group 2: 124%, ES: 5.8) were observed after both 
races. These markers decreased from 48 to 72hrs after the races, but still remained 
significantly above pre-exercise values, except for LDH in the 54km ultra-marathon. These 
results are consistent with data obtained by Millet, Tomazin [31] who pointed out that 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
more than 5 to 9 days were needed to return to pre-exercise values of LDH and myoglobin, 
respectively. A possible explanation for this might be that ultra-endurance exercise induces 
stress, which is associated with an activation of the sympathetic system and the activation 
of inflammation and muscle damage biomarkers [35]. All these results provide us with 
information on the effect of ultra-endurance events on muscle damage, mainly when the 
distance is greater. 
Several studies have shown the acute effect of biomarkers associated with cardiac injury, 
which showed significant increase after long-term activities with an eccentric component 
such as ultra-marathon mountain racing. [11, 36]. Interestingly, this study has been unable 
to demonstrate an increase of Troponine I only in 54km runners, post-race (460%, ES: 
1.4), which was higher than in 111km runners (ES: 1.1). Thus, these results are likely to be 
related to intensity and length of time of the races. These results suggest that the greater 
distances completed could increase cardiovascular diseases, as an elevated concentration of 
these two compounds are biomarkers of cardiac injury [8]. Additionally, increases were 
observed after the race in 54km runners at 24 and 48hrs and 111km athletes, at 24, 48 and 
72hrs. Moreover, greater increases in C-reactive protein were observed in athletes that ran 
the 111km race, who showed a great concentration immediately after the race (ES: 4.1) at 
24hrs (ES: 1.2) and 48hrs (ES: 1.3). These findings suggest that ultra-endurance leads to 
inflammatory reaction [6] and the distance can be associated with the severity of 
inflammation. 
The principal limitation of the present study was the low number of participants evaluated 
and inter-individual variability in response to the competitions of ultra-endurance 
mountain races. Additionally, several factors in the characteristics of the participants could 
be a bias factor of the results such as the age of the participants [37] or the body 
composition [38]. On the other hand, the present research offers an important contribution 
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to understand that ultra-endurance races can lead to muscle damage, inflammation and 
other pathologies that can put the runner’s health at risk. The findings of the current study 
do support the recent comprehensive review [6] which concluded that ultra-endurance 
events could be harmful to health but the effects on biomarkers which are associated with 
damage, inflammation, injury muscle and cardiac are reversible in a few days. In addition, 
an increase in the race distance (volume: km) seems to lead to more muscle damage and 
muscle inflammation injury. 
However, the intensity (running speed) of the race could have a greater effect on markers 
of cardiac damage. Consequently, the authors recommend that before executing an ultra-
endurance mountain race, a training program under expert supervision should be carried 
out, as well as an exhaustive medical examination. Moreover, after ultra-endurance 
mountain races, do not perform high training loads until at least 72 hours after the race. 
 
5. Conclusions  
From the current data it is possible to conclude that the athletes who completed ultra-
endurance mountain races had increased concentrations of markers associated with 
damage, inflammation, muscle injury and cardiac damage. Furthermore, athletes who 
completed a 111km had higher concentrations the biomarker associated with muscle 
damage and inflammatory processes and the 54km participants had higher concentrations 
of the markers associate with cardiac damage. The research has also shown that in 111km 
runners, the biomarkers analysed for damage, inflammation, muscle injury did not return to 
baseline values after 72hours (Erythrocytes, Hemoglobin, Hematocrit, GPT, CK, 
Myoglobin, C-reactive protein). However, in 54km runners the markers analysed returned 
to baseline values between 24 and 48 hours. Following the evidence shown in a recent 
review, it is important to carry out training specific to the competition [6]. Therefore, high 
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load training is not recommended until 48 hours after for ~50km and 72 hours for ~100km 
runners.  
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Figure1. Elevation profile of the races.  
 
Figures 2. Differences between races in effect size (IC 95%) on levels of white and red blood cells . 
ES: Effect size. Differences between races: §p<0.05. 
 
Figures 3. Differences between races in effect size (IC 95%) on biomarkers associated with muscle damage 
and inflammation cells . 
ES: Effect size. Differences between races: §p<0.05; §§p<0.01. 
  
Figures 4. Differences between races in effect size (IC 95%) on levels of biomarkers associated with muscle 
injury. 
ES: Effect size. Differences between races: §p<0.05; §§p<0.01; §§§p<0.01. 
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Table 1. Differences in levels of white and red blood cells. 
 
MCV: mean corpuscular volume; MCH: mean corpuscular haemoglobin; ES: effect size.  
Differences between before and immediately after and by 24, 48 and 72 h: 
* 
p<0.05 vs basal; 
**
 p<0.01 vs 
basal; 
***
 p<0.001 vs basal.  
Differences between race: 
§
p<0.05 
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Table 2. Differences in levels of biomarkers associated with muscle damage and inflammation. 
  
Distanc
e 
Pre-race  Post-race 24 hours 48 hours 72 hours  
  Races 
Mea
n 
±SD 
Mea
n 
±SD Δ(%) ES 
Mea
n 
±S
D 
Δ(%) ES 
Mea
n 
±S
D 
Δ(%) ES 
Mea
n 
±S
D 
Δ(%) ES 
Uric 
Acid 
(mg/dl
) 
54 Km 4.9 1.2 7.3 1.0 49.0 2.4*** 5.3 1.0 8.2 0.9* 5.2 1.1 6.1 0.6 5.1 1.1 4.1 0.5 
  111 km 5.3 0.9 6.7 0.8 26.4 2.2** 5.4 0.7 1.9 0.2 4.8 0.7 -9.4 1.0 5.0 0.8 -5.7 0.7 
GOT 
(UI/l) 
54 Km 34.7 32.7 72.0 41.6 
107.
5 
2.0*** 62.8 21.1 81.0 0.9* 43.1 11.6 24.2 0.3 34.5 6.9 -0.6 0.0 
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66.8 
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2.1**;§
§ 
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34.2 
413.
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2.7**;§
§ 
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2.1**;§
§ 
54.7 19.0 
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8 
1.9**;§ 
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72.7 64.5 
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§ 
509.
1 
56.7 51.9 
2.2**;§
§ 
GOT: glutamicoxaloacetic acid transaminase; GPT: glutamic-pyruvic acid transaminase; LDH: lactic dehydrogenase. 
Differences between before and immediately after and by 24, 48 and 72 h: 
* 
p<0.05 vs basal; 
**
 p<0.01 vs basal; 
***
 p<0.001 vs basal. 
Differences between race: 
§
p<0.05; 
§§
 p<0.01.  
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Table 3. Differences in levels of biomarkers associated with muscle injury. 
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CK: creatine kinase. NA: Not Available 
Differences between before and immediately after and by 24, 48 and 72 h: 
* 
p<0.05 vs basal; 
**
 p<0.01 vs 
basal; 
***
 p<0.001 vs basal. 
Differences between race: 
§
p<0.05; 
§§
 p<0.01; 
§§§
 p<0.001. 
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